An antibody binds a surface, not a sequence. Whether that surface can be rebuilt from a short synthetic peptide determines whether peptide-based antigens, blocking controls and mapping experiments will work for a given antibody. This page sets out the distinction and its practical consequences.
| Linear (continuous) | Conformational (discontinuous) | |
|---|---|---|
| Composition | A contiguous run of residues in the sequence | Residues from different parts of the sequence brought together by folding |
| Survives denaturation | Yes | No |
| Reproduced by a synthetic peptide | Usually | Rarely, unless the structure is constrained |
| Typical applications that work | Western blot, denatured ELISA, some IHC on fixed tissue | Immunoprecipitation, flow cytometry, native ELISA, neutralization |
| Mapped by | Overlapping peptide scanning | Mutagenesis, hydrogen-deuterium exchange MS, crystallography, phage display mimotopes |
The distinction is not absolute. Many epitopes have a dominant continuous core with additional contacts contributed by neighbouring structure, so a peptide may bind the antibody measurably but more weakly than the folded protein does. That partial behaviour is common and is often enough for a blocking experiment even when it would be too weak for capture.
When an animal is immunized with a folded protein, the B cell receptors that engage it see the protein's surface as it is presented. Surfaces of folded proteins are mostly made of residues that are far apart in sequence, so the epitopes selected are predominantly discontinuous. This is the usual explanation for a frequent and frustrating observation: a commercial antibody raised against a recombinant protein works beautifully for immunoprecipitation and poorly or not at all on a Western blot, or the reverse.
The reverse case is equally predictable. An antibody raised against a short synthetic peptide has only ever seen a linear stretch, usually in a flexible conjugated form. It recognizes that stretch. Whether the intact protein presents the same stretch in an accessible, similar conformation is a separate question that the immunization cannot answer.
If the antibody must work on denatured protein — Western blot, denaturing ELISA, many fixed-tissue protocols — a peptide antigen is well suited. If it must recognize native protein in solution or on a cell surface, a folded recombinant protein antigen has a better chance, and peptide immunization becomes a higher-risk route.
For peptide antigens, favour regions predicted to be exposed and flexible: loops, and the N- and C-termini. Buried hydrophobic stretches make poor antigens and worse reagents. Avoid regions shared with closely related family members unless cross-reactivity is wanted.
If an overlapping scan of the whole sequence shows no binding, the most likely explanation is that the epitope is conformational, not that the scan failed. That is a real and reportable result, and it redirects mapping towards mutagenesis or structural methods.
A peptide blocking control only works if the antibody recognizes the linear sequence. For an antibody with a conformational epitope, failure of a peptide to block says nothing about specificity, and a different control — knockout or knockdown material — is needed.
Two approaches partially bridge the gap. Cyclic and otherwise constrained peptides can hold a sequence in a conformation closer to the one it adopts in the protein, which sometimes restores recognition that a linear peptide loses; disulfide-bridged loops and stapled peptides are the usual forms. Separately, mimotopes are peptides selected from phage display libraries because they bind an antibody, without necessarily resembling the natural sequence at all. A mimotope can be an excellent affinity reagent or blocking control while telling you little directly about where the real epitope lies.
If a conformational epitope needs to be mimicked, say so at the design stage. A constrained design is a different synthesis from a linear peptide, and the cyclization strategy affects purification, analysis and cost. See cyclic peptides and disulfide bonds.
Paste a peptide or protein sequence to review length, charge, hydrophobicity and other properties before you order.
Research use only. LifeTein peptides and proteins are supplied for laboratory research use. They are not for human or veterinary use, and not for diagnostic or therapeutic use. See our research use policy.
Send us the target protein and the applications the antibody must support. We will advise whether a peptide antigen is the right route and which control peptides to make alongside it. Email sales@lifetein.com or use our antibody service quotation form.